Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

26 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-01

Study Completion Date

2024-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluating the relationship between prostate-specific membrane antigen positron emission tomography and arterial spin labeling perfusion imaging, and the correlation with prostate-specific membrane antigen expressed on glioblastoma microvascular.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer

NCT06054789

Prostate Cancer

UNKNOWN NA

A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer

NCT06696326

Positron-Emission Tomography(PET) Prostate Cancer Trophoblast Cell Surface Antigen 2

RECRUITING NA

Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients

NCT06690970

RECRUITING

The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture

NCT06901492

PSMA PET/CT Prostate Cancer MpMRI

NOT_YET_RECRUITING NA

99mTc-P137 SPECT/CT in Prostate Cancer

NCT05672485

Prostate Cancer

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glioblastoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Correlation between PSMA PET and ASL

The relationship between multimodal images

glioblastoma

Intervention Type DIAGNOSTIC_TEST

All patients underwent conventional MRI, ASL perfusion imaging and 68Ga-PSMA-11 PET/CT examinations within 1 week interval

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

glioblastoma

All patients underwent conventional MRI, ASL perfusion imaging and 68Ga-PSMA-11 PET/CT examinations within 1 week interval

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Newly diagnosed or recurrent glioblastoma;
* Adult (≥18 years old);

Exclusion Criteria

* The patient has a serious underlying disease or mental illness and is unable to cooperate with the imaging examination;
* Have received systematic chemotherapy;
* The image data is of poor or incomplete quality;
* pregnant women;

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No